Australian-founded AI medical scribe company Heidi has secured $100 million in funding to accelerate building its ‘AI care partners’ for clinicians.
Heidi, formerly known as Heidi Health, announced on 6 October 2025, the closing of a $100 million (US$65 million) Series B funding round. It said this was led by Point72 Private Investments with participation from continuing investors Blackbird, Headline and Latitude, the growth fund of Phoenix Court.
This round valued Heidi at $717 million (US$465 million) and brought total funding to nearly $155 million (US$100 million), it said.
Heidi said the funding would accelerate its mission to build AI care partners that sit alongside clinicians expanding their capacity by automating tasks such as clinical documentation, evidence search, and follow-up communications.
Funds would enable it to expand its headcount, office locations and local support in the US, UK and Canada, and build on clinician-led adoption in France, Spain, Germany, Ireland, South Africa, Singapore and Hong Kong.
It said research showed that clinicans spent nearly as much time on administration as on patient care.
In 18 months, it had returned more than 18 million hours to frontline clinicians worldwide by streamlining administrative tasks, and supported 73 million patient consults, it said.
CEO and co-founder, Dr Thomas Kelly, a former surgical resident at the Alfred Hospital and medical intern at the Royal Melbourne Hospital, said it was untenable that healthcare demand continued to rise while clinical time continued to shrink.
“Building a sustainable healthcare system requires expanding clinical capacity without compromising clinician wellbeing or patient safety,” he said.
“That’s why I founded Heidi: to build an AI care partner that stands alongside clinicians, empowering them to deliver the care to which they have dedicated their lives.”
In Australia, those exploring AI capabilities with Heidi included Monash Health in Melbourne and Queensland Children’s Hospital.
Mr Sri Chandrasekar, managing partner at Point72 Private Investments, said administrative burden was contributing to clinician burnout and capacity challenges across healthcare systems.
“Heidi’s platform has the potential to meaningfully improve how clinicians manage their administrative workflows,” he said.
Heidi also announced it had appointed Dr Simon Kos, former chief medical officer ANZ at Microsoft, as its chief medical officer, and Mr Paul Williamson, previously head of revenue at Plaid, as its chief revenue officer.
Dr Kos said: “Heidi’s bold vision extends beyond the current promise of ambient voice technology and into a future where every clinician can leverage AI to expand their clinical capacity while protecting the human touch in healthcare.”
The company was founded in 2019 as Oscer then rebranded to Heidi Health in 2021 before rebranding as Heidi in 2025.
More reading
Audiology case notes are everything
Audiology Australia releases AI position statement on AI scribes and notetakers
Audiology for Life! seminar a hit for Independent Audiologists Australia
